Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Amgen Inc. is a global biotechnology company that develops, manufactures, and commercializes human therapeutics for serious diseases. Its portfolio centers on biologic medicines and specialty therapies used in oncology, inflammation, cardiovascular disease, bone health, nephrology, and rare diseases. The company also markets biosimilars that provide alternatives to established biologic drugs, expanding its presence across major pharmaceutical categories. Amgen serves healthcare providers, hospitals, clinics, pharmacies, and wholesalers in markets around the world, with products distributed through both institutional and commercial channels. Its current business is built around discovering and delivering treatments that address high unmet medical needs, making Amgen a significant player in the biopharmaceutical sector and a key provider of advanced medicines within modern healthcare markets.